Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Institute of Biomedi (OP:MRES)

0.0145 +0.0005 (+3.57%)
Streaming Delayed Price Updated: 3:59 PM EDT, May 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 421,972
Open 0.0141
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0140
Today's Range 0.0140 - 0.0154
52wk Range 0.0001 - 0.0280
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MRES: Dr. Esmarilda Dankaert Appointed Chief Innovation Officer (CINO) at M2Bio Sciences
Via ACCESSWIRE
MRES: M2Bio Food and Beverage Refocuses Strategy: Expanding Beyond CBD to Reach Global Consumers
Via ACCESSWIRE

Performance

YTD
-25.3%
-25.3%
1 Month
-14.7%
-14.7%
3 Month
-27.9%
-27.9%
6 Month
+271.8%
+271.8%
1 Year
+61.1%
+61.1%

More News

Read More
MRES: M2Bio Sciences Provides Corporate Update
Via ACCESSWIRE
MRES: M2Bio Sciences Introduces M2BioKids: A Pioneering Approach to Elevating Childhood Health and Development
Via ACCESSWIRE
MRES: M2Enviro 2023 Year-End Review and 2024 Looking Forward
Via ACCESSWIRE
MRES: M2Biome 2023 Year-End Review and 2024 Looking Forward
Via ACCESSWIRE
Real American Announces Acquisition of M2MMA from MRES
Via ACCESSWIRE
MRES: M2MMA Gears Up for a Landmark Year in 2024
Via ACCESSWIRE
MRES: M2Bio Sciences Expands Global Presence with New Offices in Dubai Science Park
Via ACCESSWIRE
MRES: M2Bio Sciences Marks Milestone Expansion with Launch of Los Angeles Office
Via ACCESSWIRE
African Ginger Patented for Influenza and SARS-CoV-2 Treatment: Insights from M2Bio Sciences Research Chair
Via ACCESSWIRE
M2MMA Announces 2024 Fight Schedule and Appoints CEO
Via ACCESSWIRE
M2Bio Sciences Chair, Prof Maharaj, to Deliver Keynote Address on Cutting-Edge Biotechnology Advancements
Via ACCESSWIRE
M2Bio Sciences Closes JDAX Acquisition
Via ACCESSWIRE
M2Bio Sciences Pharmacology & Clinical Application of CBD
Via ACCESSWIRE
M2Bio-Discovery Centre for AI-Driven Phytomedicine Research: Update
Via ACCESSWIRE
M2bio Sciences Announces Launch of Exclusive MMA Organization
Via ACCESSWIRE
BioMedNewsBreaks – Institute of Biomedical Research Corp. (MRES) Names Veteran Financial Leader to Advisory Board
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioMedNewsBreaks – Institute of Biomedical Research Corp. (MRES) Unveils Meticulously Crafted Line of Teas Sourced from Kenya
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
AI-Powered Psychedelic Treatments: Special Status And Next-Gen Contests Winners
Via Benzinga
M2Bio Sciences Division M2Biome Cardiometabolic Health Launches Website
Via News Direct
M2Bio Sciences Division M2Biome Cardiometabolic Health Launches Website
Via TheNewswire.com
Innovative Holdings Alliance, Inc. Announces Brand License Agreement with M2Bio Sciences
Via ACCESSWIRE

Frequently Asked Questions

Is Institute of Biomedi publicly traded?
Yes, Institute of Biomedi is publicly traded.
What exchange does Institute of Biomedi trade on?
Institute of Biomedi trades on the OTC Traded
What is the ticker symbol for Institute of Biomedi?
The ticker symbol for Institute of Biomedi is MRES on the OTC Traded
What is the current price of Institute of Biomedi?
The current price of Institute of Biomedi is 0.0145
When was Institute of Biomedi last traded?
The last trade of Institute of Biomedi was at 05/08/25 03:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.